MENU
+Compare
SRTS
Stock ticker: NASDAQ
AS OF
Oct 27, 02:21 PM (EDT)
Price
$3.33
Change
-$0.00 (-0.00%)
Capitalization
54.91M

SRTS Sensus Healthcare Forecast, Technical & Fundamental Analysis

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system... Show more

SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SRTS with price predictions
Oct 24, 2025

SRTS in upward trend: price rose above 50-day moving average on October 23, 2025

SRTS moved above its 50-day moving average on October 23, 2025 date and that indicates a change from a downward trend to an upward trend. In of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where SRTS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 24, 2025. You may want to consider a long position or call options on SRTS as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SRTS just turned positive on October 23, 2025. Looking at past instances where SRTS's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for SRTS crossed bullishly above the 50-day moving average on October 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTS advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SRTS moved out of overbought territory on October 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SRTS broke above its upper Bollinger Band on October 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SRTS entered a downward trend on October 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SRTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.055) is normal, around the industry mean (61.698). P/E Ratio (31.500) is within average values for comparable stocks, (39.140). SRTS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.672). SRTS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (1.455) is also within normal values, averaging (80.908).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SRTS is expected to report earnings to rise 30.00% to -7 cents per share on November 06

Sensus Healthcare SRTS Stock Earnings Reports
Q3'25
Est.
$-0.08
Q2'25
Missed
by $0.07
Q1'25
Missed
by $0.21
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.08
The last earnings report on August 07 showed earnings per share of -5 cents, missing the estimate of 0 cents. With 16.23K shares outstanding, the current market capitalization sits at 54.91M.
A.I. Advisor
published General Information

General Information

a manufacturer of skin cancer treatment products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
851 Broken Sound Parkway, NW
Phone
+1 561 922-5808
Employees
35
Web
https://www.sensushealthcare.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZULQ0.620.02
+4.17%
Azul S.A.
CNLPL53.950.95
+1.79%
Connecticut Light & Power Co. (The)
CCDBF57.920.79
+1.38%
CCL Industries Inc.
AEOJF8.57N/A
N/A
Aeon Financial Services Co., Ltd.
IFUS0.04N/A
-5.04%
Impact Fusion International Inc.

SRTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
+1.52%
LUNG - SRTS
57%
Loosely correlated
+3.14%
VAPO - SRTS
35%
Loosely correlated
N/A
HOLX - SRTS
28%
Poorly correlated
+0.14%
MTD - SRTS
28%
Poorly correlated
-0.24%
PLSE - SRTS
27%
Poorly correlated
+3.91%
More

Groups containing SRTS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
+1.52%
Medical/Nursing Services
industry (218 stocks)
20%
Poorly correlated
+0.87%
Health Services
industry (425 stocks)
1%
Poorly correlated
+0.56%